A recent near miss documented event highlighted that both our backup supply spinal and epidural supply kits contained a high dose EPINEPHrine 1 mg/mL 1 mL vial in addition to lidocaine. Our frontline supply kit offering on each is a custom kit that does not contain EPINEPHrine, but when this goes on back order currently we are subject to interfacing with the kits with both lidocaine and separate high dose EPINEPHrine to my understanding. These kits are made by BBraun and Smith Medical.
I am currently in discussions with supply chain and anesthesia about the access to this concentrated vasoactive medication in this way.
What are other systems and MSOs doing to mitigate the risk of this high alert medication frequently commercially available in spinal and epidural kits? This medication flowed in our system outside of my and pharmacy's view of accessible meds through the supply chain.